ATOS icon

Atossa Therapeutics
ATOS

Overview Fund Activity

52 hedge funds and large institutions have $20.2M invested in Atossa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 3 closing their positions.

Holders
52
Holders Change
+7
Holders Change %
+15.56%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
14
Closed
3
Calls
$1.38M
Puts
$91K
Net Calls
+$1.29M
Net Calls Change
+$576K

Top Buyers

1
GCP
1
GSA Capital Partners
United Kingdom
$381K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$470K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.35M
4
VF
4
Virtu Financial
New York
$109K
5
Jane Street
5
Jane Street
New York
$99.4K

Top Sellers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$273K
2
BlackRock
2
BlackRock
New York
$3.65M
3
Millennium Management
3
Millennium Management
New York
$399K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.4M
5
State Street
5
State Street
Massachusetts
$550K
Name Holding Trade Value Shares
Change 		Shares
Change %
LNC
51
Lincoln National Corp
Pennsylvania
– -$7.5K -10,340 Closed
National Bank of Canada
52
National Bank of Canada
Quebec, Canada
– -$1K -1,400 Closed
1 2
3